Generali Investments CEE’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$940K Hold
7,950
0.04% 296
2026
Q1
$950K Hold
7,950
0.05% 288
2025
Q4
$1.08M Hold
7,950
0.08% 240
2025
Q3
$1.17M Hold
7,950
0.09% 224
2025
Q2
$1.03M Hold
7,950
0.08% 225
2025
Q1
$950K Hold
7,950
0.09% 225
2024
Q4
$922K Buy
+7,950
New +$1.01M 0.1% 213

Other funds holding XYL

Generali Investments CEE's XYL Position: Q2 2026 in Review

Generali Investments CEE held its Xylem (XYL) position steady in Q2 2026 at 7,950 shares worth $940K. The position accounts for 0.04% of the portfolio, ranked #296.

Generali Investments CEE first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.17M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Generali Investments CEE held 7,950 shares of Xylem worth $940K as of Q2 2026.
  • Generali Investments CEE left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.04% of Generali Investments CEE's portfolio in Q2 2026, its #296 holding.
  • Generali Investments CEE first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Xylem position peaked at $1.17M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.